Castellum Authorizes $6.0M Buyback, Roughly 14% of Its Market Value
CTM sits 34% above its 52-week low of $0.34 on elevated volume (3.1× avg).
Summary
Castellum's board approved repurchasing up to $6.0 million of stock over 12 months starting November 12, 2026, funded from $15.7 million of cash and no debt. The authorization is discretionary and equals a large slice of the company's market value.
Key Events · Financing and Capital Events · CTM
-
Board Approves $6.0M Buyback
Castellum may repurchase up to $6.0 million of common stock over a 12-month period commencing November 12, 2026, through open-market or privately negotiated transactions under Rule 10b-18.
-
Funded From $15.7M Cash
Repurchases are expected to be funded with available cash, which totaled $15.7 million as of September 30, 2026, and the company carries no debt.
-
Discretionary, No Obligation
The program does not obligate Castellum to buy any specific number of shares and may be modified, suspended, or discontinued at any time; timing depends on market conditions and liquidity.
-
Follows Q3 Net Loss
The authorization comes days after the November 5, 2026 10-Q reported a $453,904 net loss for Q3 2026, so buybacks compete with organic growth and acquisition spending.
Analysis · CTM · Trade & Services
For a micro-cap valued near $43 million, a $6.0 million repurchase authorization is a substantial commitment, and it is backed by $15.7 million of cash with no debt. Management is effectively signaling that the shares are undervalued at current levels and that buybacks can be funded while acquisitions continue. Because the program is discretionary — there is no obligation to buy any specific amount — the real test is whether repurchases actually show up in later filings. The timing also matters: it comes days after a Q3 report showing a $453,904 net loss, making the buyback a capital-allocation choice while the core business is still losing money.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTM was trading at $0.46 on NYSE in the Trade & Services sector, with a market capitalization of approximately $42.8M. The 52-week trading range was $0.34 to $1.27. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.